SOPHSOPHiA GENETICS SA

Nasdaq sophiagenetics.com


$ 4.82 $ 0.22 (4.78 %)    

Thursday, 09-May-2024 15:55:35 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 4.82
$ 4.63
$ 0.00 x 0
$ 0.00 x 0
$ 4.63 - $ 4.94
$ 2.13 - $ 7.37
133,905
na
314.41M
$ 1.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sophia-genetics-q1-2024-gaap-eps-021-beats-028-estimate-sales-15779m-miss-16467m-estimate

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.2...

 sophia-genetics-and-strand-life-sciences-enter-new-strategic-partnership-to-advance-the-use-of-precision-medicine

The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics t...

 sophia-genetics-announces-first-homologous-recombination-deficiency-customer-in-canada

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

 sophia-genetics-and-the-french-kidney-cancer-research-network-uroccr-publish-results-from-multiyear-collaboration-on-a-study-using-a-multimodal-algorithm-to-predict-post-operative-outcomes-for-those-facing-renal-cell-carcinoma

The findings of the study showed the artificial intelligence (AI) model co-constructed by SOPHiA GENETICS and UroCCR provided a...

 why-united-natural-foods-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

 btig-maintains-buy-on-sophia-genetics-raises-price-target-to-8

BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $7 to $8.

 rbc-capital-reiterates-outperform-on-sophia-genetics-maintains-8-price-target

RBC Capital analyst Conor McNamara reiterates Sophia Genetics (NASDAQ:SOPH) with a Outperform and maintains $8 price target.

 why-crowdstrike-shares-are-trading-higher-by-around-24-here-are-20-stocks-moving-premarket

Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company rep...

 oddity-tech-posts-q4-results-joins-ross-stores-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday.

 why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

 sophia-genetics-forecasts-2024-revenue-of-78m-81m-up-25-30-yoy-compared-to-consensus-of-8211m

Adjusted gross margin between 72.5% and 72.7%, compared to 72.2% in FY 2023 Adjusted operating loss between $45M and $50M, c...

 sophia-genetics-q4-gaap-eps-037-misses-027-estimate-sales-1705m-miss-1733m-estimate

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0...

 earnings-scheduled-for-march-5-2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION